{"public_id":"co_d30f81b7f6ac73e5c0b242631c8b418f","status":"active","merged_into_public_id":null,"resolved_public_id":"co_d30f81b7f6ac73e5c0b242631c8b418f","name":"PI3K/AKT/mTOR inhibitors","description":"Targeted drugs that inhibit the PI3K/AKT/mTOR signaling pathway.","aliases":[],"types":["therapeutic class"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":9880383,"title":"Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets.","citation_count":901,"url":"https://sah.borca.ai/papers/9880383"}],"claims":[{"public_id":"cl_8725573026ae54c9e6a72b3f4b524e71","text":"Alterations associated with sensitivity to PI3K/AKT/mTOR, CDK, and HER2/EGFR inhibitors were detected in brain metastases, indicating that primary biopsies alone may miss opportunities for targeted therapy.","corpus_id":9880383,"url":"https://sah.borca.ai/claims/cl_8725573026ae54c9e6a72b3f4b524e71"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_d30f81b7f6ac73e5c0b242631c8b418f","url":"https://sah.borca.ai/concepts/co_d30f81b7f6ac73e5c0b242631c8b418f"}